Georges Gay, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 116 Carriage Court Ln, Concord, VA 24538 Phone: 804-919-4411 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement") with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.
Political ads often stretch facts to the breaking point, but the people who create them usually feel constrained to back up their claims by citing sources -; at least enough to keep neutral fact-checkers from exposing their work as fiction. Not so in this year's presidential campaign. There's no nice way to say this: President Obama and Republican challenger Mitt Romney are both condoning deliberate falsehoods.
Drug safety warnings issued by the U.S. Food and Drug Administration (FDA) don't always lead to targeted changes in the way medications are prescribed and used, reports a study in the June issue of Medical Care.
Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).
Hormone researchers at the University of Houston (UH) have their sights set on providing long-term treatment options for diabetes, obesity and cardiovascular diseases by better understanding estradiol, the most potent naturally occurring estrogen.
› Verified 1 days ago